# Zoledronic Acid

## Aclasta inj 5mg/100mL

| TAH Drug Code      | [IACL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IACL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment and prevention of postmenopausal osteoporosis. Treatment to increase bone mass in men with osteoporosis. Treatment and prevention of glucocorticoid-induced osteoporosis. Treatment of Paget’s disease of bone in men and women.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | IVD, 5 mg once every year.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypocalcemia. Patients with creatinine clearance less than 35 mL/min and in those with evidence of acute renal impairment. Hypersensitivity to any component of Aclasta.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Common Cardiovascular: Peripheral edema (Paget disease, 3%; osteoporosis, 4.6% to 5.5%; osteopenia, 3.9% to 5.6%; hypercalcemia of malignancy, 5% to less than 10%; bone metastasis, 21% ) Endocrine metabolic: Weight decreased (bone metastasis, 16% ) Gastrointestinal: Abdominal pain (osteoporosis (female), 0.9% to 4.6%; osteoporosis (male), 7.9%; osteoporosis (male and female), 7.5%; osteopenia, 6.6% to 8.6%; Paget disease, 2%; hypercalcemia of malignancy, 16%; bone metastasis, 14% ), Constipation (Paget disease, 6%; hypercalcemia of malignancy, 27% ), Diarrhea (osteoporosis, 5.2% to 6%; osteopenia, 6.6% to 8.1%; Paget disease, 6%; hypercalcemia of malignancy, 17%; bone metastasis, 24% ), Loss of appetite (osteoporosis, 1% to 2%; osteopenia, 0.6% to 2%; Paget disease, 2%; hypercalcemia of malignancy, 9%; bone metastasis, 22% ), Nausea (osteoporosis (female), 4.5% to 8.5%; osteoporosis (male and female), 9.6%; osteopenia, 11.6% to 17.7%; Paget disease, 9%; hypercalcemia of malignancy, 29%; bone metastasis, 46% ), Vomiting (Paget disease, 2%; osteoporosis, 3.4% to 4.6%; osteopenia, 5% to 7.6%; hypercalcemia of malignancy, 14%; bone metastasis, 32% ) Musculoskeletal: Arthralgia (Osteoporosis (female), 17.9% to 23.8%, (acute phase, 3% to 7%); osteoporosis (male, acute phase), 11.1%; osteopenia, 18.8% to 27.3%, (acute phase, 6.1%); hypercalcemia of malignancy, 5% to less than 10%; Paget disease, 9%; bone metastasis, 21% ), Backache (Osteoporosis (male and female), 4.3%; osteoporosis (male, acute phase), 3.3%; osteopenia, 16.6% to 18.2%, (acute phase, 1.7%); Paget disease, 4%; bone metastasis, 15% ), Pain in limb (Osteoporosis (female), 5.9% to 11.3%; osteoporosis (male and female), 3.1%; osteopenia, 11.1% to 16%, (acute phase, 3.9%); bone metastasis, 14% ) Neurologic: Asthenia (osteoporosis, 3.2 to 5.3%; osteopenia, 2.8% to 6.1%; Paget disease, 2%; hypercalcemia of malignancy, 5% to less than 10%; bone metastasis, 24% ), Dizziness (osteoporosis, 2% to 7.6%; osteopenia, 6.1% to 7.6%; Paget disease, 9%; bone metastasis, 18% ), Headache (osteoporosis (female), 3.9% to 12.4%, (acute phase, 7%); osteoporosis (male), 15%, (acute phase, 9.8%); osteopenia, 14.6% to 20.4%, (acute phase, 13.3%); Paget disease, 11%; hypercalcemia of malignancy, 5% to less than 10%; bone metastasis, 19% ), Insomnia (hypercalcemia of malignancy, 15%; bone metastasis, 16% ), Paresthesia (Paget disease, 2%; bone metastasis, 15% .) Renal: Nephrotoxicity (bone metastasis, 11% to 17% ) Other: Fatigue (osteoporosis (female), 2.1% to 5.4%; osteoporosis (male), 17.6%, (acute phase, 12.4%); osteopenia, 9.9% to 14.6%, (acute phase, 8.3%); Paget disease, 8%; bone metastasis, 39% ), Fever (osteoporosis (female, acute phase), 7% to 18%; osteoporosis (male, acute phase), 15.7%; osteopenia, 21% to 21.7% (acute phase, 19.3%); Paget disease, 3% to 11%; hypercalcemia of malignancy (acute phase), 44%; bone metastasis, 32% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Bolenic IV infusion 4mg

| TAH Drug Code      | [IBOL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBOL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumor-induced hypercalcemia) in patients with advanced malignancies involving bone. Treatment of hypercalcemia of malignancy (HCM).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | IVD, 4 mg once every 3-4 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Known hypersensitivity to zoledronic acid or other bisphosphonates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Very common: Hypophosphatemia. Common: Anemia, headache, conjunctivitis, nausea, vomiting, anorexia, bone pain, myalgia, arthralgia, renal impairment, fever, flu-like syndrome, blood creatinine & blood urea increase, hypocalcemia. Cardiovascular: Peripheral edema (Paget's Disease, 3%; osteoporosis, 4.6% to 5.5%; bone metastasis, 21% ) Endocrine metabolic: Weight decreased (bone metastasis, 16% ) Gastrointestinal: Abdominal pain (osteoporosis (female), 0.9% to 4.6%; osteoporosis (male), 7.9%; Paget's disease, 2%; hypercalcemia of malignancy, 16%; bone metastasis, 14% ), Constipation (Paget's disease, 6%; hypercalcemia of malignancy, 27%; bone metastasis, 31% ), Diarrhea (osteoporosis, 5.2% to 6%; Paget's disease, 6%; hypercalcemia of malignancy, 17%; bone metastasis, 24% ), Loss of appetite (osteoporosis, 1% to 2%; Paget's disease, 2%; hypercalcemia of malignancy, 9%; bone metastasis, 22% ), Nausea (osteoporosis, 4.5% to 8.5%; Paget's disease, 9%; hypercalcemia of malignancy, 29%; bone metastasis, 46% ), Vomiting (Paget's disease, 2%; osteoporosis, 3.4% to 4.6%; hypercalcemia of malignancy, 14%; bone metastasis, 32% ) Musculoskeletal: Arthralgia (osteoporosis (female), 17.9% to 23.8%; osteoporosis (male), 11.1%; hypercalcemia of malignancy, 5% to less than 10%; Paget's disease, 9%; bone metastasis, 21% ), Backache (Paget's disease, 4%; bone metastasis, 15% ) Neurologic: Asthenia (osteoporosis, 3.2 to 5.3%; Paget's disease, 2%; bone metastasis, 24% ), Dizziness (osteoporosis, 2% to 7.6%; Paget's disease, 9%; bone metastasis, 18% ), Headache (osteoporosis (female), 3.9% to 12.4%; osteoporosis (male), 15%; Paget's disease, 11%; hypercalcemia of malignancy, 5% to less than 10%; bone metastasis, 19% ), Insomnia (hypercalcemia of malignancy, 15%; bone metastasis, 16% ), Paresthesia (Paget's disease, 2%; bone metastasis, 15% .) Renal: Nephrotoxicity (bone metastasis, 11% to 17% ) Other: Fatigue (osteoporosis (female), 2.1% to 5.4%; osteoporosis (male), 17.6%; Paget's disease, 8%; bone metastasis, 39% ), Fever (osteoporosis (female), 7% to 18%; osteoporosis (male), 15.7%; Paget's disease, 3% to 11%; hypercalcemia of malignancy, 44%; bone metastasis, 32% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

